GB2124077B - Immunomodulating agent - Google Patents

Immunomodulating agent

Info

Publication number
GB2124077B
GB2124077B GB08311536A GB8311536A GB2124077B GB 2124077 B GB2124077 B GB 2124077B GB 08311536 A GB08311536 A GB 08311536A GB 8311536 A GB8311536 A GB 8311536A GB 2124077 B GB2124077 B GB 2124077B
Authority
GB
United Kingdom
Prior art keywords
carbon atoms
alkyl group
hydrogen
immunomodulating agent
chem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08311536A
Other languages
English (en)
Other versions
GB8311536D0 (en
GB2124077A (en
Inventor
Hiroaki Munakata
Makio Kobayashi
Kazuo Wagatsuma
Shigeru Sato
Makota Tsurufuji
Hiroshi Enomoto
Makoto Sugiyama
Yoshihisa Shibata
Iwao Morita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Mitsubishi Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd, Mitsubishi Chemical Industries Ltd filed Critical Nippon Shinyaku Co Ltd
Publication of GB8311536D0 publication Critical patent/GB8311536D0/en
Publication of GB2124077A publication Critical patent/GB2124077A/en
Application granted granted Critical
Publication of GB2124077B publication Critical patent/GB2124077B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GB08311536A 1982-05-11 1983-04-27 Immunomodulating agent Expired GB2124077B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57078893A JPS58194814A (ja) 1982-05-11 1982-05-11 免疫調節作用を有する薬剤

Publications (3)

Publication Number Publication Date
GB8311536D0 GB8311536D0 (en) 1983-06-02
GB2124077A GB2124077A (en) 1984-02-15
GB2124077B true GB2124077B (en) 1986-12-03

Family

ID=13674488

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08311536A Expired GB2124077B (en) 1982-05-11 1983-04-27 Immunomodulating agent

Country Status (12)

Country Link
US (1) US4720506A (enExample)
EP (1) EP0094599B1 (enExample)
JP (1) JPS58194814A (enExample)
AT (1) ATE26212T1 (enExample)
BE (1) BE896712A (enExample)
CH (1) CH656800A5 (enExample)
DE (2) DE3317107A1 (enExample)
FR (1) FR2526659B1 (enExample)
GB (1) GB2124077B (enExample)
IT (1) IT1200011B (enExample)
NL (1) NL8301639A (enExample)
SE (1) SE8302694L (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8522186D0 (en) * 1985-09-06 1985-10-09 Erba Farmitalia Cycloalkyl-substituted 4-aminophenyl derivatives
US6037376A (en) * 1991-10-21 2000-03-14 The United States Of America As Represented By The Department Of Health And Human Services Methods for therapy of cancer
US5635532A (en) * 1991-10-21 1997-06-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Compositions and methods for therapy and prevention of pathologies including cancer, AIDS and anemia
US5605930A (en) * 1991-10-21 1997-02-25 The United States Of America As Represented By The Department Of Health And Human Services Compositions and methods for treating and preventing pathologies including cancer
CA2120367C (en) * 1992-06-30 2004-05-11 Howard K. Shapiro Compositions and use of pharmaceutical compositions in the treatment of symptoms of disorders related to chronic inflammatory diseases and etiologically related symptomology
EP0759750A4 (en) * 1994-05-11 1998-05-27 Howard K Shapiro PREPARATIONS FOR TREATING CHRONIC FLAMMABLE DISEASES
WO1996018607A1 (en) * 1994-12-12 1996-06-20 Chugai Seiyaku Kabushiki Kaisha Aniline derivative having the effect of inhibiting nitrogen monoxide synthase
ATE311358T1 (de) 2000-08-29 2005-12-15 Nobex Corp Immunoregulierende verbindungen, deren derivate und ihre verwendung
GB0113366D0 (en) * 2001-06-01 2001-07-25 Ks Biomedix Ltd Composition
US8048924B2 (en) 2001-08-29 2011-11-01 Biocon Limited Methods and compositions employing 4-aminophenylacetic acid compounds
ITMI20012434A1 (it) * 2001-11-20 2003-05-20 Dompe Spa Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono
RU2228175C1 (ru) * 2002-12-10 2004-05-10 Лимонов Виктор Львович Иммуностимулятор
RU2245142C1 (ru) * 2003-07-14 2005-01-27 Лимонов Виктор Львович Иммуномодулятор
RU2253445C1 (ru) * 2003-12-02 2005-06-10 Лимонов Виктор Львович Иммуномодулятор
RU2253447C1 (ru) * 2003-12-08 2005-06-10 Лимонов Виктор Львович Иммуномодулятор
WO2005084658A1 (en) * 2004-03-04 2005-09-15 Arakis Ltd. Derivatives of actarit and their therapeutic use
PL1773767T3 (pl) 2004-07-07 2016-07-29 Biocon Ltd Synteza azowo związanych związków immunoregulacyjnych
GB0423927D0 (en) * 2004-10-27 2004-12-01 Arakis Ltd The treatment of IBD
ITRM20050389A1 (it) 2005-07-22 2007-01-23 Giuliani Spa Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico.
UA107562C2 (uk) 2008-12-05 2015-01-26 Спосіб лікування псоріазу
EA020856B1 (ru) 2009-02-16 2015-02-27 Джулиани Интернэшнл Лимитед Способы лечения патологических состояний, связанных с волосами
JP6301844B2 (ja) 2012-02-09 2018-03-28 ノグラ ファーマ リミテッド 線維症の処置方法
EP2844242A1 (en) 2012-04-18 2015-03-11 Nogra Pharma Limited Methods of treating lactose intolerance
CN106278925B (zh) * 2016-08-08 2019-01-25 平光制药股份有限公司 一种对乙酰氨基苯乙酸的制备方法
EP3921299B1 (en) 2019-02-08 2024-11-20 Nogra Pharma Limited Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL133740C (enExample) * 1965-04-08
GB1082466A (en) * 1965-06-29 1967-09-06 Smith & Nephew 2-benzamidophenylalkanoic acid derivatives and their preparation
US3641040A (en) * 1968-03-27 1972-02-08 Ciba Geigy Corp Tertiary amino phenyl acetic acids
DE1913742A1 (de) * 1968-03-27 1969-10-09 Ciba Geigy Tertiaere aliphatische Aminosaeuren
DE2034240C2 (de) * 1968-03-27 1982-12-02 CIBA-GEIGY AG, 4002 Basel Isoindolinderivate, Verfahren zur Herstellung dieser Verbindungen und deren Verwendung
FR2193579A2 (en) * 1972-07-25 1974-02-22 Bouchara Emile Para amino phenyl acetic acids - analgesics and antiinflammatories, prepd. by alkylation of prim amino acid
US3997669A (en) * 1972-12-26 1976-12-14 Ciba-Geigy Corporation Tertiary aminoacids
JPS5572167A (en) * 1978-11-27 1980-05-30 Dainippon Pharmaceut Co Ltd Pyridylaminophenylacetic acid derivative and its preparation

Also Published As

Publication number Publication date
US4720506A (en) 1988-01-19
FR2526659B1 (fr) 1986-07-04
SE8302694L (sv) 1983-11-12
GB8311536D0 (en) 1983-06-02
DE3317107A1 (de) 1983-11-24
EP0094599B1 (en) 1987-04-01
DE3370585D1 (en) 1987-05-07
BE896712A (fr) 1983-11-10
GB2124077A (en) 1984-02-15
JPS58194814A (ja) 1983-11-12
SE8302694D0 (sv) 1983-05-10
ATE26212T1 (de) 1987-04-15
EP0094599A1 (en) 1983-11-23
CH656800A5 (de) 1986-07-31
IT8321018A0 (it) 1983-05-10
NL8301639A (nl) 1983-12-01
FR2526659A1 (fr) 1983-11-18
IT1200011B (it) 1989-01-05
JPH0211568B2 (enExample) 1990-03-14

Similar Documents

Publication Publication Date Title
GB8311536D0 (en) Immunomodulating agent
AU4083589A (en) ((1-lower alkyloxy-1-methyl)ethoxy)amines
WO1988000042A1 (en) New 5-alkoxy-2,4-diamino-alkyl benzols, and hair tinting means using them
GR76342B (enExample)
AU591640B2 (en) Quinolonecarboxylic acid derivatives
PT79813B (en) Process for the preparation of purin derivatives with antiviral properties
DE3666226D1 (en) Process for the preparation of 1,2-dithiolan-3-pentanoic acid (thioctic acid)
PT83104B (en) Novel guanidinomethylbenzoic acid derivatives
EP0228845A3 (en) N-containing heterocyclic compounds, processes for the preparation thereof and composition comprising the same
AU1395283A (en) 1-carboxyalkanoylindoline-2-carboxylic acid esters
GR3007460T3 (enExample)
AU576887B2 (en) 1,6-naphthyridine derivatives
MX170732B (es) Composicion de derivados de succinimida y su uso
EP0143564A3 (en) Crown ether derivatives
FR2498184B1 (enExample)
ES8301931A1 (es) Un procedimiento para la preparacion de nuevos imidazoles.
GR3001551T3 (en) Derivatives of benzoquinonyl-phenyl alkanoic acid amide
GB2231570B (en) Naphthalenepropionic acid salts
ZA906247B (en) Novel imidazole derivatives,process for the preparation of the same and antiulcer agents containing the same
IL75430A0 (en) Pineapple ketone carbonate derivatives and their use as flavoring agents
ES8200092A1 (es) Procedimiento para la sintesis de esteres de la n-(4'hidro- xifenil) acetamida con acidos 5-benzoil-1-metilpirrol-2-ace-tico
IL78625A0 (en) Furanone derivatives and their preparation
CA1273347C (enExample)
EP0308319A3 (en) 4-piperidinecarboxamide derivatives
ES8205220A1 (es) Procedimiento para la obtencion de esteres del acido succi- nico de efecto antibacterial y antiprotozoal

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee